Immune cells supercharged to fight advanced skin cancer
NCT ID NCT05098184
First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a treatment made from a patient's own immune cells (called TILs) to fight advanced melanoma. Doctors take a sample of the tumor, grow the immune cells in a lab, and then put them back into the patient. The goal is to shrink tumors and control the cancer, but patients may need ongoing treatment or monitoring. The study is for people who have tried other treatments without success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.